vs

Side-by-side financial comparison of BRANDYWINE REALTY TRUST (BDN) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

BRANDYWINE REALTY TRUST is the larger business by last-quarter revenue ($127.0M vs $121.8M, roughly 1.0× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs -38.4%, a 42.6% gap on every dollar of revenue. On growth, BRANDYWINE REALTY TRUST posted the faster year-over-year revenue change (4.5% vs -1.4%). Over the past eight quarters, BRANDYWINE REALTY TRUST's revenue compounded faster (0.7% CAGR vs -3.4%).

Brandywine Realty Trust is a Philadelphia-based real estate investment trust (REIT) that invests in office buildings in Philadelphia, Washington, D.C., and Austin, Texas.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BDN vs CLB — Head-to-Head

Bigger by revenue
BDN
BDN
1.0× larger
BDN
$127.0M
$121.8M
CLB
Growing faster (revenue YoY)
BDN
BDN
+6.0% gap
BDN
4.5%
-1.4%
CLB
Higher net margin
CLB
CLB
42.6% more per $
CLB
4.2%
-38.4%
BDN
Faster 2-yr revenue CAGR
BDN
BDN
Annualised
BDN
0.7%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
BDN
BDN
CLB
CLB
Revenue
$127.0M
$121.8M
Net Profit
$-48.8M
$5.1M
Gross Margin
Operating Margin
1.2%
1.5%
Net Margin
-38.4%
4.2%
Revenue YoY
4.5%
-1.4%
Net Profit YoY
-80.4%
EPS (diluted)
$-0.28
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BDN
BDN
CLB
CLB
Q1 26
$127.0M
$121.8M
Q4 25
$121.0M
$138.3M
Q3 25
$121.4M
$134.5M
Q2 25
$120.6M
$130.2M
Q1 25
$121.5M
$123.6M
Q4 24
$121.9M
$129.2M
Q3 24
$131.8M
$134.4M
Q2 24
$125.3M
$130.6M
Net Profit
BDN
BDN
CLB
CLB
Q1 26
$-48.8M
$5.1M
Q4 25
$-36.7M
$4.9M
Q3 25
$-25.9M
$14.2M
Q2 25
$-88.7M
$10.6M
Q1 25
$-27.0M
$-154.0K
Q4 24
$-44.5M
$7.4M
Q3 24
$-165.2M
$11.7M
Q2 24
$30.2M
$9.0M
Gross Margin
BDN
BDN
CLB
CLB
Q1 26
Q4 25
61.3%
20.8%
Q3 25
62.6%
22.0%
Q2 25
62.4%
20.3%
Q1 25
60.8%
19.5%
Q4 24
61.2%
17.8%
Q3 24
64.9%
20.5%
Q2 24
63.1%
21.2%
Operating Margin
BDN
BDN
CLB
CLB
Q1 26
1.2%
1.5%
Q4 25
22.8%
11.5%
Q3 25
20.8%
15.6%
Q2 25
-34.3%
11.7%
Q1 25
12.5%
3.6%
Q4 24
18.0%
11.0%
Q3 24
-7.2%
14.7%
Q2 24
15.5%
12.3%
Net Margin
BDN
BDN
CLB
CLB
Q1 26
-38.4%
4.2%
Q4 25
-30.3%
3.6%
Q3 25
-21.3%
10.6%
Q2 25
-73.5%
8.2%
Q1 25
-22.2%
-0.1%
Q4 24
-36.5%
5.7%
Q3 24
-125.4%
8.7%
Q2 24
24.1%
6.9%
EPS (diluted)
BDN
BDN
CLB
CLB
Q1 26
$-0.28
$0.11
Q4 25
$-0.21
$0.11
Q3 25
$-0.15
$0.30
Q2 25
$-0.51
$0.22
Q1 25
$-0.16
$0.00
Q4 24
$-0.25
$0.15
Q3 24
$-0.96
$0.25
Q2 24
$0.17
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BDN
BDN
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$36.2M
$22.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
Total Assets
$3.6B
$587.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BDN
BDN
CLB
CLB
Q1 26
$36.2M
$22.8M
Q4 25
$32.3M
$22.7M
Q3 25
$75.5M
$25.6M
Q2 25
$122.6M
$31.2M
Q1 25
$29.4M
$22.1M
Q4 24
$90.2M
$19.2M
Q3 24
$36.5M
$21.5M
Q2 24
$30.4M
$17.7M
Total Debt
BDN
BDN
CLB
CLB
Q1 26
Q4 25
$2.6B
$110.3M
Q3 25
$2.3B
$114.1M
Q2 25
$2.3B
$124.6M
Q1 25
$2.2B
$124.4M
Q4 24
$2.2B
$126.1M
Q3 24
$2.3B
$139.9M
Q2 24
$2.2B
$147.6M
Stockholders' Equity
BDN
BDN
CLB
CLB
Q1 26
$275.1M
Q4 25
$792.7M
$266.0M
Q3 25
$841.5M
$271.3M
Q2 25
$879.8M
$261.3M
Q1 25
$993.6M
$253.4M
Q4 24
$1.0B
$246.6M
Q3 24
$1.1B
$250.7M
Q2 24
$1.3B
$240.3M
Total Assets
BDN
BDN
CLB
CLB
Q1 26
$3.6B
$587.7M
Q4 25
$3.6B
$584.0M
Q3 25
$3.3B
$591.4M
Q2 25
$3.4B
$602.1M
Q1 25
$3.4B
$591.5M
Q4 24
$3.5B
$585.1M
Q3 24
$3.6B
$600.5M
Q2 24
$3.8B
$597.8M
Debt / Equity
BDN
BDN
CLB
CLB
Q1 26
Q4 25
3.23×
0.41×
Q3 25
2.70×
0.42×
Q2 25
2.63×
0.48×
Q1 25
2.23×
0.49×
Q4 24
2.13×
0.51×
Q3 24
2.06×
0.56×
Q2 24
1.73×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BDN
BDN
CLB
CLB
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BDN
BDN
CLB
CLB
Q1 26
$4.0M
Q4 25
$116.7M
$7.9M
Q3 25
$47.5M
$8.5M
Q2 25
$34.4M
$13.9M
Q1 25
$6.3M
$6.7M
Q4 24
$181.1M
$20.6M
Q3 24
$52.2M
$13.1M
Q2 24
$48.2M
$17.1M
Free Cash Flow
BDN
BDN
CLB
CLB
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
BDN
BDN
CLB
CLB
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
BDN
BDN
CLB
CLB
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
BDN
BDN
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.60×
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BDN
BDN

Rents$120.7M95%
Third party management fees, labor reimbursement and leasing$4.7M4%

CLB
CLB

Segment breakdown not available.

Related Comparisons